تحميل...

NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer

Ionizing radiation (IR) is a key therapeutic regimen for many head and neck cancers (HNCs). However, the 5-year overall survival rate for locally-advanced HNCs is ∼50% and better therapeutic efficacy is needed. NAD(P)H:quinone oxidoreductase 1 (NQO1) is over-expressed in many cancers, and β-lapachon...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Mol Cancer Ther
المؤلفون الرئيسيون:	Li, Long-Shan, Reddy, Srilakshmi, Lin, Zhen-Hua, Liu, Shuangping, Park, Hyunsil, Chun, Stephen G., Bornmann, William G., Thibodeaux, Joel, Yan, Jingsheng, Chakrabarti, Gaurab, Xie, Xian-Jin, Sumer, Baran D., Boothman, David A., Yordy, John S.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	2016
الموضوعات:	Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC5123441/ https://ncbi.nlm.nih.gov/pubmed/27196777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0765
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer

مواد مشابهة